Clinical Study on the Efficacy of Tirzepatide for Chronic Heart Failure Complicated Diabetes

Clinical Study on the Efficacy of Tirzepatide for Chronic Heart Failure Complicated Diabetes - Clinical Study on the Efficacy of Tirzepatide for Chronic Heart Failure Complicated Diabetes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054143

Enrollment

Registered

2024-04-13

Start date

2024-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure with diabetes mellitus and BMI over 25

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Obesity with diabetes mellitus and BMI over 25

Exclusion criteria

Exclusion criteria: Patients who were deemed not appropriate to participate in this study by doctor

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
1) Body weight 2) BMI 3) Insulin, CPR 4) BUN, Cr, eGFR 5) AST, ALT 6) T-cho, LDL, HDL, TG 7) Cystatin C 8) Oxidized LDL, High-sensitivity CRP 9) NTProBNP, BNP, ANP 10) Fatty acid fraction 11) Albuminuria 12) Fat CT (Total fat amount, Visceral fat amount, Subcutaneous fat amount) 13) Side effects	—

Countries

Japan

Contacts

Public ContactMitsue Akiyama

Sekino Laboratory Department of Research

skn-np@sekino-hospital.com03-3986-5501

Outcome results